Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: Shamrock Industrial Company Limited

Market Cap 116M 1.21M 1.05M 969K 908K 1.7M 1.73M 11.56M 4.48M 55.91M 4.55M 4.45M 194M P/E Ratio 2024
-128x
P/E Ratio 2025 -53.4x
Enterprise Value 116M 1.21M 1.05M 968K 907K 1.69M 1.73M 11.55M 4.47M 55.84M 4.54M 4.44M 194M EV / Sales 2024
38,257,531x
EV / Sales 2025 -
Free-Float
48.09%
Yield 2024 *
-
Yield 2025 -
30/05 Shamrock Industrial Company Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
12/02 Shamrock Industrial Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
23/12 Shamrock Industrial Company Limited Approves the Proposals for Incorporation of Wholly Owned Subsidiaries CI
23/12 Shamrock Industrial Company Limited Approves the Proposals for Incorporation of Wholly Owned Subsidiaries CI
11/12 Shamrock Industrial Company Limited Announces Incorporation of Wholly Owned Subsidiary HODL Energy Private Limited in India CI
15/11 Shamrock Industrial Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
13/11 Lotus Excel Wealth Creators LLP, HODL Systems LLP, Bagepalli Vijaykumar Harish and Rattan Kapoor completed the acquisition of 0.38% stake in Shamrock Industrial Company Limited for INR 0.34 million. CI
29/10/25 Shamrock Industrial appoints Rahul Manoj Rajani as chief financial officer RE
29/10/25 Shamrock Industrial Company Limited Approves Appointment of Rahul Manoj Rajani as Chief Financial Officer, Effective October 28, 2025 CI
29/10/25 Shamrock Industrial Company Limited Announces Board Appointments, Effective October 28, 2025 CI
17/10/25 Shamrock Industrial Company Limited Announces Resignation of Jitesh Rameshchandra Khokhani as Chief Financial Officer, with Effect from Closure of Business Hours of October 16, 2025 CI
17/10/25 Shamrock Industrial Company Limited Announces Board Resignations, with Effect from October 16, 2025 CI
12/08/25 Shamrock Industrial Company Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
1 day+4.99%
1 week+4.99%
Current month+4.99%
1 month+10.20%
3 months+15.66%
6 months+27.49%
Current year+21.44%
1 week 23.56
Extreme 23.56
23.56
1 month 22.44
Extreme 22.44
23.56
Current year 19.4
Extreme 19.4
23.56
1 year 15.98
Extreme 15.98
23.56
3 years 3.34
Extreme 3.34
23.56
5 years 3.16
Extreme 3.16
23.56
10 years 3.16
Extreme 3.16
23.56
Manager TitleAgeSince
Chief Executive Officer - 16/10/2025
Director of Finance/CFO - 28/10/2025
Chief Operating Officer - 28/10/2025
Director TitleAgeSince
Director/Board Member - 22/06/2021
Director/Board Member - 21/04/2022
Director/Board Member - 16/10/2025
Change 5-day change 1-year change 3-year change Capi.($)
+4.99%+4.99%+47.43%+333.09% 1.34M
+2.42%+3.58%+44.15%+161.75% 1,013B
+0.35%+5.00%+54.31%+49.83% 574B
+0.81%+0.78%+18.38%+64.60% 397B
-0.37%+4.97%+21.24%+15.95% 324B
+0.85%+0.18%+24.50%+14.78% 280B
+2.10%+4.92%+25.30%+33.80% 273B
+5.45%+2.75%+21.69%+63.37% 182B
-0.19%-0.46%-45.32%-48.35% 194B
+4.26%-1.91%+15.93%+62.74% 151B
Average +2.05%+2.88%+22.76%+75.16% 338.86B
Weighted average by Cap. +1.54%+3.99%+29.93%+73.29%

Financials

2024 2025
Net sales 1.12 0.01 0.01 0.01 0.01 0.02 0.02 0.11 0.04 0.54 0.04 0.04 1.87 -
Net income -406K -4.24K -3.68K -3.39K -3.18K -5.94K -6.06K -40.46K -15.66K -196K -15.92K -15.57K -680K -1.26M -13.16K -11.42K -10.53K -9.86K -18.43K -18.81K -126K -48.62K -607K -49.4K -48.33K -2.11M
Net Debt -9.31M -97.23K -84.38K -77.78K -72.88K -136K -139K -928K -359K -4.49M -365K -357K -15.6M -137K -1.43K -1.24K -1.14K -1.07K -2K -2.05K -13.65K -5.29K -66.04K -5.37K -5.26K -230K
Logo Shamrock Industrial Company Limited
Shamrock Industrial Company Limited is an India-based pharmaceuticals company. The Company offers a diverse range of manufacturing of pharmaceuticals and drugs products and allied business activities. It offers its products for various therapeutic uses, including anti-coagulants (anti-platelet), radio-protective agents, platelet regulator, anti-depressants, anti-neo plastics and immunosuppressants, antihistamines, sympathomimetics, anti-hypertensives, diuretic, anti-diabetic, calcium regulating agents, local anesthetics and anti-bacterial. Its active pharmaceutical ingredient (API) product list (manufactured) includes acenocomarol, amifostine, ciclopirox, cilazapril, losartan potassium, metaxalone, metoprolol succinate and pregabalin. The Company's API product list (contract manufactured) includes abacavir, acarbose, oxaliplatin, oxaprozin, finasteride, frusemide and colchicine.
Employees
1
Date Price Change Volume
08/06/26 23.56 +4.99% 3,519
  1. Stock Market
  2. Stocks
  3. 531240 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!